Argitalpenak (32) Manuel Guzmán Navarro argitalpenak

2024

  1. Useful Role of a New Generation of Dexamethasone, Vitamin E and Human Serum Albumin Microparticles in the Prevention of Excitotoxicity Injury in Retinal Ocular Diseases

    Pharmaceutics, Vol. 16, Núm. 3

2023

  1. Desarrollo de una formulación antiglaucomatosa tópica a partir de una lágrima artificial

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2018

  1. Novel Nano-liposome formulation for dry eyes with components similar to the preocular tear film

    Polymers, Vol. 10, Núm. 4

2017

  1. Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends

    International Journal of Pharmaceutics

2016

  1. Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives

    International Journal of Pharmaceutics

  2. Novel water-soluble mucoadhesive carbosilane dendrimers for ocular administration

    Molecular Pharmaceutics, Vol. 13, Núm. 9, pp. 2966-2976

  3. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration

    European Journal of Pharmaceutical Sciences, Vol. 92, pp. 287-297

2014

  1. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 12, pp. 7839-7847

2012

  1. Synthesis and fluorescent properties of cationic carbosilane dendrimers containing eugenol linkers for their use in biomedical applications

    New Journal of Chemistry, Vol. 36, Núm. 2, pp. 360-370

2002

  1. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres

    Journal of Microencapsulation, Vol. 19, Núm. 1, pp. 61-72

2001

  1. Cyclosporine-loaded polycaprolactone nanoparticles: Immunosuppression and nephrotoxicity in rats

    European Journal of Pharmaceutical Sciences, Vol. 12, Núm. 4, pp. 471-478

  2. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats

    Pharmazie, Vol. 56, Núm. 1, pp. 78-82

2000

  1. Biodegrable nanoparticles as a delivery system for cyclosporine: Preparation and characterization

    Journal of Microencapsulation, Vol. 17, Núm. 5, pp. 599-614

  2. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose

    International Journal of Pharmaceutics, Vol. 197, Núm. 1-2, pp. 129-141

  3. Effect of nanoparticles on digitoxin uptake and pharmacologic activity in rat glomerular mesangial cell cultures

    Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, Vol. 7, Núm. 4, pp. 215-222

  4. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Núm. 3, pp. 379-387

1999

  1. A polycaprolactone nanoparticle formulation of cyclosporin-a improves the prediction of area under the curve using a limited sampling strategy

    International Journal of Pharmaceutics, Vol. 187, Núm. 1, pp. 101-113

  2. Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers

    European Journal of Pharmaceutical Sciences, Vol. 8, Núm. 2, pp. 99-107

1998

  1. Age and sex dependent pharmacokinetics of cyclosporine in the rat after a single intravenous dose

    International Journal of Pharmaceutics, Vol. 174, Núm. 1-2, pp. 9-18

  2. Nuevas formas de administracion del interferon

    Farmacia Clinica